Anna Tsimelzon

发表

Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients.

Syed Mohsin, Susan G Hilsenbeck, Michael T Lewis, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Research resource: expression profiling reveals unexpected targets and functions of the human steroid receptor RNA activator (SRA) gene.

Bert W O'Malley, B. O’Malley, M. Tsai, 2010, Molecular endocrinology.

Gene expression patterns for doxorubicin (Adriamycin) and cyclophosphamide (Cytoxan) (AC) response and resistance

Alan Ashworth, Mitch Dowsett, A. Ashworth, 2006, Breast Cancer Research and Treatment.

Ductal Carcinoma In situ and the Emergence of Diversity during Breast Cancer Evolution

Charles M. Perou, Iris D. Nagtegaal, D. Craig Allred, 2008, Clinical Cancer Research.

Development of resistance to targeted therapies transforms the clinically associated molecular profile subtype of breast tumor xenografts.

Jiang Shou, Susan G Hilsenbeck, Chad J Creighton, 2008, Cancer research.

SAFB1 Mediates Repression of Immune Regulators and Apoptotic Genes in Breast Cancer Cells*

Steffi Oesterreich, Shiming Jiang, Chad J. Creighton, 2009, The Journal of Biological Chemistry.

Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis.

Adrian V. Lee, Susan G Hilsenbeck, Chad J Creighton, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Identification of tumor-initiating cells in a p53-null mouse model of breast cancer.

Daniel Medina, Fariba Behbod, Mei Zhang, 2008, Cancer research.

Identification of Novel Kinase Targets for the Treatment of Estrogen Receptor–Negative Breast Cancer

John Quackenbush, Carolina Gutierrez, John Quackenbush, 2009, Clinical Cancer Research.

Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer

Syed Mohsin, Susan G Hilsenbeck, S. Hilsenbeck, 2003, The Lancet.

Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer

Gordon B Mills, Kyle R Covington, Susan G Hilsenbeck, 2014, Clinical Cancer Research.

Global gene expression analysis of estrogen receptor transcription factor cross talk in breast cancer: identification of estrogen-induced/activator protein-1-dependent genes.

S. Hilsenbeck, P. Brown, D. DeNardo, 2005, Molecular endocrinology.

High IGF-IR Activity in Triple-Negative Breast Cancer Cell Lines Correlates with Sensitivity to IGF-IR Inhibitor BMS-754807 in This Subtype of Human Breast Cancer.

Jeffrey T. Chang, Adrian V. Lee, B. Litzenburger, 2009 .

A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models.

Chad A Shaw, Gordon B Mills, Charles M Perou, 2013, Cancer research.